Company: BLNE
Filing Date: 2025-02-05
Form Type: DEF 14A
Source: 0001493152-25-005006
Chunk: 31

Company: Beeline Holdings, Inc.
Filing Date: 2025-02-05
Form: DEF 14A
Chunk 31
---
 for more information on poxy and voting procedures for the Special Meeting. Q: Whom should I contact with questions? A:If you have additional questions about the Proposals or the Special Meeting, you should contact us at: Eastside Distilling, Inc., 755 Main Street, Building 4, Suite 3, Monroe, Connecticut, 06468, or by phone at +1 458-800-9154.

| 28 |

<div align='center'>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

This Proxy Statement, as well as information included in oral statements or other written statements made or to be made by us, contain statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are neither historical facts nor assurances of future performance. These forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which could cause our actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in the Risk Factors in our final Prospectus filed with the SEC on January 14, 2025. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements

<div align='center'>PROPOSAL 1: THE MERGER SHARE ISSUANCE PROPOSAL</div>

At the Special Meeting shareholders as of the Record Date will be asked to approve The Merger Share Issuance Proposal, which provides for the approval, for purposes of complying with Nasdaq Rule 5635(b), of the issuance of shares of common stock in excess of the Exchange Cap of 19.99% of the Company’s outstanding common stock as of October 7, 2024 in connection with and following the Merger and the common stock issuable upon conversion or exercise of the Series F, Series F-1 and the Derivatives, as well as the Series G, the G Warrants and the Note Warrants.

The following discussion